Jazz Pharmaceuticals plc — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/28585c7d-7781-4bab-b2b6-d811befccf75/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $4.3B | 2025-01-01 – 2025-12-31 | evidence 0001232524-26-000013 |
| FY 2024 | $4.1B | 2024-01-01 – 2024-12-31 | evidence 0001232524-25-000011 |
| FY 2023 | $3.8B | 2023-01-01 – 2023-12-31 | evidence 0001232524-24-000015 |
| FY 2022 | $3.7B | 2022-01-01 – 2022-12-31 | evidence 0001232524-23-000015 |
| FY 2021 | $3.1B | 2021-01-01 – 2021-12-31 | evidence 0001232524-22-000012 |
| FY 2020 | $2.4B | 2020-01-01 – 2020-12-31 | evidence 0001232524-21-000016 |
| FY 2019 | $2.2B | 2019-01-01 – 2019-12-31 | evidence 0001232524-20-000016 |
| FY 2018 | $1.9B | 2018-01-01 – 2018-12-31 | evidence 0001232524-19-000013 |
| FY 2017 | $1.6B | 2017-01-01 – 2017-12-31 | evidence 0001232524-19-000013 |
| FY 2016 | $1.5B | 2016-01-01 – 2016-12-31 | evidence 0001232524-19-000013 |
| FY 2015 | $1.3B | 2015-01-01 – 2015-12-31 | evidence 0001232524-16-000194 |
| FY 2014 | $1.2B | 2014-01-01 – 2014-12-31 | evidence 0001232524-15-000030 |
| FY 2013 | $865.4M | 2013-01-01 – 2013-12-31 | evidence 0001232524-14-000012 |
| FY 2012 | $580.5M | 2012-01-01 – 2012-12-31 | evidence 0001232524-13-000010 |
| FY 2011 | $266.5M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-085849 |
| FY 2010 | $170.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-085849 |
| FY 2009 | $115.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-085849 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Jazz Pharmaceuticals plc — all facts · Net Income · Operating Income